| Dr William Cardasis, MD | |
|
202 E Washington St, Ste 208, Ann Arbor, MI 48104-2017 | |
| (734) 747-9345 | |
| (734) 747-9328 |
| Full Name | Dr William Cardasis |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 33 Years |
| Location | 202 E Washington St, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326198276 | NPI | - | NPPES |
| 3254893K | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084F0202X | Psychiatry & Neurology - Forensic Psychiatry | 4301058250 (Michigan) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301058250 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Olma Specialty 1 Llc | 6901206689 | 39 |
News Archive
Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.
A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person's risk of schizophrenia and bipolar disorder.
A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
› Verified 4 days ago
| Entity Name | St Mary Mercy Physician Practices |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568630077 PECOS PAC ID: 4587742804 Enrollment ID: O20080425000614 |
News Archive
Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.
A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person's risk of schizophrenia and bipolar disorder.
A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
› Verified 4 days ago
| Entity Name | St Mary Mercy Hospital Professional |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528145554 PECOS PAC ID: 2365521226 Enrollment ID: O20080502000426 |
News Archive
Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.
A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person's risk of schizophrenia and bipolar disorder.
A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
› Verified 4 days ago
| Entity Name | Iha Olma Specialty 1 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891371118 PECOS PAC ID: 6901206689 Enrollment ID: O20210617000949 |
News Archive
Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.
A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person's risk of schizophrenia and bipolar disorder.
A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Cardasis, MD 16801 Yorkshire St, Livonia, MI 48154-6108 Ph: (734) 458-1076 | Dr William Cardasis, MD 202 E Washington St, Ste 208, Ann Arbor, MI 48104-2017 Ph: (734) 747-9345 |
News Archive
Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.
A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person's risk of schizophrenia and bipolar disorder.
A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
› Verified 4 days ago
Ernesto F Figueroa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Hogback Road, Suite 19, Ann Arbor, MI 48105 Phone: 734-677-5900 | |
Dushyant G. Trivedi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 555 William St., Suite #24c, Ann Arbor, MI 48104 Phone: 734-994-1171 Fax: 734-712-5745 | |
Dr. Edwin Seymour Tobes, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 117 N 1st St, Suite 103, Ann Arbor, MI 48104 Phone: 734-649-4623 | |
Dr. Joyce Danielski Kales, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-769-7100 Fax: 734-769-7091 | |
Dr. Louis William Feurino Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 Victors Way 240, Ann Arbor, MI 48108 Phone: 313-605-5330 Fax: 734-661-0322 | |
Benjamin Martin Bly, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, 1st Floor University Hospital Room 1b300, Ann Arbor, MI 48109 Phone: 734-936-9035 Fax: 734-936-5520 | |
Hao Cheng, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 425-502-5290 |